InVivo adds New Jersey's Cooper Neurological as clinical site: 5 points

Spinal Tech

InVivo Therapeutics added Cooper Neurological Institute in Camden, N.J., as a new clinical site for its Neuro-Spinal Scaffold investigational study.

Here are five points:

 

1. The Neuro-Spinal Scaffold is used for acute spinal cord injury treatment.

 

2. Steven Yocom, DO, professor of neurosurgery and co-director of Cooper Neurological Institute is the principal investigator at the new site.

 

3. A total of 13 clinical sites are open for enrollment.

 

4. This is the first clinical study of its investigational degradable polymer Neuro-Spinal Scaffold.

 

5. The FDA approved the pilot study and it is expected to capture preliminary safety and effectiveness data in five subjects with acute thoracic spinal cord injury.

 

"Our group has a particular interest in spinal trauma and spinal cord injury," said Dr. Yocom. "I'm excited that InVivo is approaching the significant unmet medical need in this field with such a novel technology."

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers